Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Ra Pharmaceuticals, Inc. ()
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
17 Mar 2020
Ricardo Alonso
See Remarks, Officer
Ra Pharmaceuticals, Inc.
(RARX)
0
-100%
2,288
$44.25
$101,244.00
SELL
16 Mar 2020
Farzaneh-Far Ramin
Chief Medical Officer, Officer
Ra Pharmaceuticals, Inc.
(RARX)
7,132
-59%
10,595
$45.16
$478,521.03
SELL
18 Feb 2020
Farzaneh-Far Ramin
Chief Medical Officer, Officer
Ra Pharmaceuticals, Inc.
(RARX)
7,132
-59%
10,595
$46.61
$493,849.90
SELL
17 Jan 2020
Ricardo Alonso
See Remarks, Officer
Ra Pharmaceuticals, Inc.
(RARX)
2,288
-49%
2,285
$47.02
$107,440.70
SELL
15 Jan 2020
Farzaneh-Far Ramin
Chief Medical Officer, Officer
Ra Pharmaceuticals, Inc.
(RARX)
7,132
-59%
10,595
$46.95
$497,440.56
SELL
17 Dec 2019
Ricardo Alonso
See Remarks, Officer
Ra Pharmaceuticals, Inc.
(RARX)
4,573
-33%
2,285
$47.08
$107,568.44
SELL
17 Dec 2019
Read Simon
Chief Scientific Officer, Officer
Ra Pharmaceuticals, Inc.
(RARX)
6,234
-61%
10,000
$47.08
$470,821.00
SELL
16 Dec 2019
Farzaneh-Far Ramin
Chief Medical Officer, Officer
Ra Pharmaceuticals, Inc.
(RARX)
7,132
-59%
10,595
$47.23
$500,351.00
SELL
15 Nov 2019
Farzaneh-Far Ramin
Chief Medical Officer, Officer
Ra Pharmaceuticals, Inc.
(RARX)
7,132
-59%
10,595
$46.66
$494,319.25
SELL
14 Nov 2019
Read Simon
Chief Scientific Officer, Officer
Ra Pharmaceuticals, Inc.
(RARX)
6,234
-61%
10,000
$46.68
$466,808.00
SELL
17 Oct 2019
Ricardo Alonso
See Remarks, Officer
Ra Pharmaceuticals, Inc.
(RARX)
6,858
-24%
2,285
$46.70
$106,709.50
SELL
16 Oct 2019
Read Simon
Chief Scientific Officer, Officer
Ra Pharmaceuticals, Inc.
(RARX)
6,234
-61%
10,000
$46.87
$468,726.00
SELL
15 Oct 2019
Farzaneh-Far Ramin
Chief Medical Officer, Officer
Ra Pharmaceuticals, Inc.
(RARX)
7,132
-59%
10,595
$46.89
$496,768.80
SELL
16 Sep 2019
Farzaneh-Far Ramin
Chief Medical Officer, Officer
Ra Pharmaceuticals, Inc.
(RARX)
7,132
-59%
10,595
$25.26
$267,675.25
SELL
12 Sep 2019
Read Simon
Chief Scientific Officer, Officer
Ra Pharmaceuticals, Inc.
(RARX)
6,234
-61%
10,000
$25.41
$254,050.00
SELL
23 Aug 2019
Read Simon
Chief Scientific Officer, Officer
Ra Pharmaceuticals, Inc.
(RARX)
6,234
-61%
10,000
$27.77
$277,703.00
SELL
23 Aug 2019
Farzaneh-Far Ramin
Chief Medical Officer, Officer
Ra Pharmaceuticals, Inc.
(RARX)
7,132
-59%
10,595
$27.77
$294,226.30
SELL
23 Aug 2019
Ricardo Alonso
See Remarks, Officer
Ra Pharmaceuticals, Inc.
(RARX)
9,143
-19%
2,285
$27.89
$63,739.84
SELL
17 Jul 2019
Read Simon
Chief Scientific Officer, Officer
Ra Pharmaceuticals, Inc.
(RARX)
6,234
-61%
10,000
$32.95
$329,479.00
SELL
15 Jul 2019
Farzaneh-Far Ramin
Chief Medical Officer, Officer
Ra Pharmaceuticals, Inc.
(RARX)
11,348
-48%
10,595
$33.10
$350,647.25
SELL
21 Jun 2019
Ricardo Alonso
See Remarks, Officer
Ra Pharmaceuticals, Inc.
(RARX)
11,428
-20%
2,857
$23.72
$67,781.76
SELL
18 Jun 2019
Read Simon
Chief Scientific Officer, Officer
Ra Pharmaceuticals, Inc.
(RARX)
6,648
-60%
10,000
$22.25
$222,467.44
SELL
17 Jun 2019
Farzaneh-Far Ramin
Chief Medical Officer, Officer
Ra Pharmaceuticals, Inc.
(RARX)
14,316
-42%
10,595
$21.84
$231,384.02
BUY
14 Dec 2018
NEW ENTERPRISE ASSOCIATES 13 LP
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
6,135,234
+11%
645,161
$15.50
$9,999,996.00
BUY
14 Dec 2018
RA CAPITAL MANAGEMENT, LLC
Director, 10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
4,858,260
+26%
1,006,452
$15.50
$15,600,006.00
BUY
12 Dec 2018
Shah Rajeev M.
Director, 10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
4,858,260
+26%
1,006,452
$15.50
$15,600,006.00
BUY
16 Feb 2018
NEW ENTERPRISE ASSOCIATES 13 LP
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
5,490,073
+57%
2,000,000
$6.00
$12,000,000.00
BUY
14 Feb 2018
RA CAPITAL MANAGEMENT, LLC
Director, 10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
3,851,808
+184%
2,500,000
$6.00
$15,000,000.00
BUY
14 Feb 2018
Shah Rajeev M.
Director, 10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
3,851,808
+184%
2,500,000
$6.00
$15,000,000.00
SELL
16 Jun 2017
Novartis Bioventures Ltd
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
2,251,457
-2%
56,420
$21.29
$1,201,106.00
SELL
8 Jun 2017
Novartis Bioventures Ltd
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
2,307,877
-0%
700
$22.00
$15,400.00
SELL
6 Jun 2017
Novartis Bioventures Ltd
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
2,308,577
-0%
12,114
$22.63
$274,160.22
SELL
2 Jun 2017
Novartis Bioventures Ltd
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
2,320,691
-0%
19,647
$23.38
$459,437.06
SELL
31 May 2017
Novartis Bioventures Ltd
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
2,340,338
-1%
46,261
$23.93
$1,107,072.50
SELL
25 May 2017
Novartis Bioventures Ltd
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
2,386,599
-0%
5,353
$25.14
$134,592.44
SELL
24 May 2017
Novartis Bioventures Ltd
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
2,391,952
-0%
17,451
$25.01
$436,364.00
SELL
18 May 2017
Novartis Bioventures Ltd
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
2,409,403
-0%
9,019
$25.50
$229,963.75
SELL
16 May 2017
Novartis Bioventures Ltd
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
2,418,422
-1%
42,615
$25.90
$1,103,625.60
SELL
22 Feb 2017
Novartis Bioventures Ltd
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
2,461,037
-3%
84,615
$20.96
$1,773,163.90
BUY
31 Oct 2016
NEW ENTERPRISE ASSOCIATES 13 LP
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
80,223
+131%
338,027
$13.00
$4,394,351.00
BUY
31 Oct 2016
BARRIS PETER J
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
80,223
+131%
338,027
$13.00
$4,394,351.00
BUY
31 Oct 2016
MOTT DAVID M
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
80,223
+131%
338,027
$13.00
$4,394,351.00
BUY
31 Oct 2016
RA CAPITAL MANAGEMENT, LLC
Director
Ra Pharmaceuticals, Inc.
(RARX)
1,351,808
+13%
161,538
$13.00
$2,099,994.00
BUY
31 Oct 2016
KOLLURI KRISHNA KITTU
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
80,223
+131%
338,027
$13.00
$4,394,351.00
BUY
31 Oct 2016
SANDELL SCOTT D
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
80,223
+131%
338,027
$13.00
$4,394,351.00
BUY
31 Oct 2016
MORGENTHALER VENTURE PARTNERS IX LP
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
79,821
+143%
263,198
$13.00
$3,421,574.00
BUY
31 Oct 2016
Shah Rajeev M.
Director
Ra Pharmaceuticals, Inc.
(RARX)
1,351,808
+13%
161,538
$13.00
$2,099,994.00
BUY
31 Oct 2016
Novartis Bioventures Ltd
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
62,575
+388%
84,276
$13.00
$1,095,588.00
BUY
31 Oct 2016
Novo A/S
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
2,031,562
+13%
246,154
$13.00
$3,200,002.00
BUY
31 Oct 2016
Weller Harry R
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
80,223
+131%
338,027
$13.00
$4,394,351.00
BUY
31 Oct 2016
Viswanathan Ravi
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
80,223
+131%
338,027
$13.00
$4,394,351.00
BUY
31 Oct 2016
Lettmann Jason
Director
Ra Pharmaceuticals, Inc.
(RARX)
79,821
+125%
393,583
$13.00
$5,116,579.00
BUY
31 Oct 2016
KERINS PATRICK J
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
80,223
+131%
338,027
$13.00
$4,394,351.00
BUY
31 Oct 2016
BASKETT FOREST
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
80,223
+131%
338,027
$13.00
$4,394,351.00
BUY
31 Oct 2016
BARRETT M JAMES
10% Owner
Ra Pharmaceuticals, Inc.
(RARX)
80,223
+131%
338,027
$13.00
$4,394,351.00
Home